In Veritas Medical Diagnostics, Inc. (IVME)

Market Cap	25.82K
Revenue (ttm)	n/a
Net Income (ttm)	-3.13M
Shares Out	86.05M
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25,000
Average Volume	82,056
Open	0.0003
Previous Close	n/a
Day's Range	0.0003 - 0.0003
52-Week Range	0.0001 - 0.0001
Beta	9.91
RSI	43.05
Earnings Date	n/a

About IVME

In Veritas Medical Diagnostics, Inc., a development stage company, engages in the research and development of medical devices with `near-patient' testing applications. Its primary product includes prothrombin monitor, which is used for the measurement of coagulation of blood in patients at risk of heart disease and stroke. The company’s other products under development include predictor of labor onset, a consumer device for maternity planning; biomarker monitor for the measurement of a number of biomarkers, including heart attack, HIV, choleste...

• Industry: Shell Companies
• Sector: Financials
• CEO: G. Cooper
• Employees: 8
• Stock Exchange: OTCMKTS
• Ticker Symbol: IVME